AbCellera Biologics (NASDAQ:ABCL) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

AbCellera Biologics reported in-line EPS of $-0.14 versus an estimate of $-0.14.

Revenue was down $304.39 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.12% drop in the share price the next day.

Here's a look at AbCellera Biologics's past performance:

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.